49 CFR 40.193 - What happens when an employee does not provide a sufficient amount of urine for a drug test?

Cite as49 CFR 40.193
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
45 practice notes
  • Pasternack v. Lab. Corp. of Am., 10 Civ. 4426(PGG).
    • United States
    • United States District Courts. 2nd Circuit. United States District Courts. 2nd Circuit. Southern District of New York
    • September 6, 2012
    ...the “Remarks” line of the CCF (Step 2), and immediately notify the DER [Designated Employer Representative]. This is a refusal to test.49 C.F.R. § 40.193 (emphasis added). 40.191 What is a refusal to take a DOT drug test, and what are the consequences? (a) As an employee, you have refused t......
  • Pasternack v. Lab. Corp. of Am. Holdings
    • United States
    • New York Court of Appeals
    • June 30, 2016
    ...40 ounces of fluid distributed reasonably through a three-hour period, or until the employee has provided a sufficient urine specimen (49 C.F.R. 40.193 ; United States Department of Transportation, Office of Drug and Alcohol Policy and Compliance, Urine Specimen Collection Guidelines [Dec. ......
  • Pasternack v. Lab. Corp. of Am. Holdings
    • United States
    • New York Court of Appeals
    • June 30, 2016
    ...40 ounces of fluid distributed reasonably through a three-hour period, or until the employee has provided a sufficient urine specimen (49 C.F.R. 40.193 ; United States Department of Transportation, Office of Drug and Alcohol Policy and Compliance, Urine Specimen Collection Guidelines [Dec. ......
  • Pasternack v. Lab. Corp. of America, 10 Civ. 4426 (PGG)
    • United States
    • United States District Courts. 2nd Circuit. United States District Courts. 2nd Circuit. Southern District of New York
    • September 6, 2012
    ...the "Remarks" line of the CCF (Step 2), and immediately notify the DER [Designated Employer Representative]. This is a refusal to test.49 C.F.R. § 40.193 (emphasis added).Page 440.191 What is a refusal to take a DOT drug test, and what are the consequences?(a) As an employee, you have refus......
  • Request a trial to view additional results
42 cases
  • Pasternack v. Lab. Corp. of Am. Holdings
    • United States
    • New York Court of Appeals
    • June 30, 2016
    ...40 ounces of fluid distributed reasonably through a three-hour period, or until the employee has provided a sufficient urine specimen (49 C.F.R. 40.193 ; United States Department of Transportation, Office of Drug and Alcohol Policy and Compliance, Urine Specimen Collection Guidelines [Dec. ......
  • Pasternack v. Lab. Corp. of Am. Holdings
    • United States
    • New York Court of Appeals
    • June 30, 2016
    ...40 ounces of fluid distributed reasonably through a three-hour period, or until the employee has provided a sufficient urine specimen (49 C.F.R. 40.193 ; United States Department of Transportation, Office of Drug and Alcohol Policy and Compliance, Urine Specimen Collection Guidelines [Dec. ......
  • Pasternack v. Lab. Corp. of Am., No. 10 Civ. 4426(PGG).
    • United States
    • United States Courts of Appeals. United States Court of Appeals (5th Circuit)
    • September 6, 2012
    ...the “Remarks” line of the CCF (Step 2), and immediately notify the DER [Designated Employer Representative]. This is a refusal to test.49 C.F.R. § 40.193 (emphasis added). 40.191 What is a refusal to take a DOT drug test, and what are the consequences? (a) As an employee, you have refused t......
  • Pasternack v. Lab. Corp. of America, 10 Civ. 4426 (PGG)
    • United States
    • United States Courts of Appeals. United States Court of Appeals (5th Circuit)
    • September 6, 2012
    ...the "Remarks" line of the CCF (Step 2), and immediately notify the DER [Designated Employer Representative]. This is a refusal to test.49 C.F.R. § 40.193 (emphasis added).Page 440.191 What is a refusal to take a DOT drug test, and what are the consequences?(a) As an employee, you have refus......
  • Request a trial to view additional results
2 firm's commentaries

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT